475 related articles for article (PubMed ID: 10942742)
21. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
23. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
24. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
[TBL] [Abstract][Full Text] [Related]
25. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
Silka MJ; Kron J; Dunnigan A; Dick M
Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
[TBL] [Abstract][Full Text] [Related]
26. CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial.
Martinelli M; Rassi A; Marin-Neto JA; de Paola AA; Berwanger O; Scanavacca MI; Kalil R; de Siqueira SF
Am Heart J; 2013 Dec; 166(6):976-982.e4. PubMed ID: 24268211
[TBL] [Abstract][Full Text] [Related]
27. Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
Chatzidou S; Kontogiannis C; Tsilimigras DI; Georgiopoulos G; Kosmopoulos M; Papadopoulou E; Vasilopoulos G; Rokas S
J Am Coll Cardiol; 2018 May; 71(17):1897-1906. PubMed ID: 29699616
[TBL] [Abstract][Full Text] [Related]
28. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Anderson JL
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
[TBL] [Abstract][Full Text] [Related]
29. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
[TBL] [Abstract][Full Text] [Related]
30. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Connolly SJ; Dorian P; Roberts RS; Gent M; Bailin S; Fain ES; Thorpe K; Champagne J; Talajic M; Coutu B; Gronefeld GC; Hohnloser SH;
JAMA; 2006 Jan; 295(2):165-71. PubMed ID: 16403928
[TBL] [Abstract][Full Text] [Related]
31. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
32. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
33. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
[TBL] [Abstract][Full Text] [Related]
34. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Haverkamp W; Eckardt L; Borggrefe M; Breithardt G
Am J Cardiol; 1997 Oct; 80(8A):67G-73G. PubMed ID: 9354413
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest.
Chan PS; Krumholz HM; Spertus JA; Curtis LH; Li Y; Hammill BG; Nallamothu BK;
Am Heart J; 2015 Jun; 169(6):870-878.e1. PubMed ID: 26027626
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.
Owens DK; Sanders GD; Harris RA; McDonald KM; Heidenreich PA; Dembitzer AD; Hlatky MA
Ann Intern Med; 1997 Jan; 126(1):1-12. PubMed ID: 8992917
[TBL] [Abstract][Full Text] [Related]
37. Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial.
Halonen J; Loponen P; Järvinen O; Karjalainen J; Parviainen I; Halonen P; Magga J; Turpeinen A; Hippeläinen M; Hartikainen J; Hakala T
Ann Intern Med; 2010 Dec; 153(11):703-9. PubMed ID: 21135293
[TBL] [Abstract][Full Text] [Related]
38. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
Block M; Hammel D; Böcker D; Borggrefe M; Breithardt G
Am J Cardiol; 1996 Sep; 78(5A):62-8. PubMed ID: 8820838
[TBL] [Abstract][Full Text] [Related]
39. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias.
Satomi K; Kurita T; Takatsuki S; Yokoyama Y; Chinushi M; Tsuboi N; Nitta T; Shoda M; Mitamura H
Circ J; 2006 Aug; 70(8):977-84. PubMed ID: 16864928
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
